Biodesix, Inc. Common Stock — Graphique, cours et actualités (NASDAQ:BDSX) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Market Capitalization 139.04 M
Employee 334
Founded 2005
CEO N/A
Website www.biodesix.com
Headquarter Delaware, United States
FIGI BBG001J2LMV6
Industry Diagnostic et Recherche

Chiffre d'affaires total

Résultat net

Bénéfice par action de base (BPA de base)

Dette totale

Flux de trésorerie disponible

Trésorerie et équivalents de trésorerie

ratio cours/bénéfice

-1.46

ratio cours/chiffre d'affaires

0.58

Nouvelles

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?

Canaccord relève l’objectif de cours de Biodesix à 22$ sur fond de croissance du chiffre d’affaires

Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript

Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates

Are Medical Stocks Lagging Aura Biosciences (AURA) This Year?

LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?

Here's Why You Should Add DexCom Stock to Your Portfolio Now

MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

Brookdale Senior Q1'26 Sneak Peek: Occupancy Volume Rises to 82.1%